ESTRO37_ProgrammeBook

20-24 April 2018 Barcelona, Spain

PROGRAMME BOOK & EXHIBITION GUIDE

Innovation for Value and Access

WWW.ESTRO.ORG

20-24 April 2018 Barcelona, Spain

ESTRO European Society for Radiotherapy & Oncology

Rue Martin V, 40 1200 Brussels Belgium

WWW.ESTRO.ORG

Table of contents

GENERAL INFORMATION

7

Welcome letter | 9 Scientific and organising committees | 11 About ESTRO | 15 CME accrediation | 18

General information | 19 Acknowledgements | 24

ESTRO AWARDS

27

Awards overview | 28 Awardees’ biographies | 30

PROGRAMME

47

Pre-meeting courses | 48 ESTRO-CARO-RANZCR session | 58 Contouring workshops | 60 Multidisciplinary tumour board sessions | 62 Young scientists programme | 64

SCIENTIFIC PROGRAMME Saturday 21 April 2018 | 68 Sunday 22 April 2018 | 102 Monday 23 April 2018 | 140 Tuesday 24 April 2018 | 174

67

GENERAL INFORMATION | Programme and Exhibition Guide

4

POSTERS AND ELECTRONIC POSTERS

189

Posters | 190 Electronic posters | 243

COMMUNITIES PAVILION

393

Communities Pavilion | 394 Floorplan | 395 Communities Pavilions' details | 396

COMPANY AWARDS

399

Company awards overview | 400 Awardees’ biographies | 401

SATELLITE SYMPOSIA

407

Pre-meeting satellite symposium | 408 Satellite symposia | 409

EXHIBITION

425

Acknowledgments | 427 Floorplan | 429 Exhibitors’ details |430 Start-up corner exhibitors' details | 443

Programme and Exhibition Guide | GENERAL INFORMATION

5

NOTES

NOTES | Programme and Exhibition Guide

6

NOTES

GENERAL INFORMATION

Welcome letter

9

Scientific and organising committees

11

About ESTRO

15

CME accrediation

18

General information

19

Acknowledgements

24

Programme and Exhibition Guide | NOTES

7

GENERAL INFORMATION | Programme and Exhibition Guide

8

Welcome letter

“

It is my privilege and great pleasure to welcome you to ESTRO 37.

ESTRO is an interdisciplinary society where radiation oncologists, medical physicists, radiobiologists, brachytherapists and radiation therapists aspire to join forces with other organisations in the oncology field that share ESTRO’s vision of excellence in cancer treatment. At ESTRO 37, we draw attention to the multidisciplinary and interdisciplinary components of our practice, with emphasis on the new opportunities that they represent for all professionals of oncology, not only in research but also in the daily care of patients.

Yolande Lievens ESTRO President and ESTRO 37 Chair

The interdisciplinary component of the scientific programme include sessions on the following topics: • Big data to better radiotherapy • Costs and value of radiotherapy innovations: how to assess • Global Task Force on Radiotherapy for Cancer Control • Is there any ground for boost brachytherapy in the time of high precision IGRT/IMRT? • MR guided radiotherapy: the new standard of care in 10 years’ time • Oligometastatic disease • Patient Reported Outcomes (PROs) in radiotherapy • Radiomics and imaging databases for precision radiation oncology • Radiotherapy plus immunotherapy combination: rationale and results so far • Response adapted treatment • Safety and clinical and cost effectiveness of multi-modality IGRT and ART • Selection of patients and radiotherapy technique for APBI in the light of new phase III trial data • Targeting tumor heterogeneity • This house believes that 20 years from now, due to the advances in technology, the need for human input in radiotherapy will be minimal • Waiting times and QA

The educational aspects of ESTRO 37 will include pre-meeting courses, contouring workshops, teaching lectures and multidisciplinary tumor board sessions.

Programme and Exhibition Guide | GENERAL INFORMATION

9

As in previous conferences, ESTRO 37 offers a Young scientists track. This track is fully organised by our young members and it enables them to meet young colleagues, share common interests, network and start to build their own collaborative projects at an international level. All of the leading exhibitors contribute to ESTRO 37, Europe’s largest industrial exhibition in radiation oncology, offering the opportunity to view the latest radiotherapy technology and cancer treatment products.

We are pleased to welcome you in Barcelona.

With warm regards, Yolande Lievens ESTRO President and ESTRO 37 Chair

”

GENERAL INFORMATION | Programme and Exhibition Guide

10

Scientific and organising committees

ESTRO 37 Chair of the Congress: Y. Lievens (BE)

Scientific Programme Committee (SPC) Chair: Y. Lievens (BE)

Scientific Advisory Group (SAG) Chairs: U. Ricardi (IT), Chair, Interdisciplinary track K. Haustermans (BE), Chair, SAG Clinical Radiotherapy M. Schwarz (IT), Chair, SAG Radiation Physics C. Kirisits (AT), Chair, SAG Brachytherapy A. Chalmers (UK), Chair, SAG Radiobiology F. Moura (PT), Chair, SAG Radiation Therapy

L. Dubois (NL), Chair, Young track P. Franco (IT), Chair, Young track

Members: M. Baumann (DE), J-E. Bibault (FR), P. Blanchard (FR), B. Heijmen (NL), M. Leech (IE), J. Lindegaard (DK), L. Muren (DK), J. Overgaard (DK), P. Poortmans (FR), W. van Elmpt (NL), C. Vens (NL)

Scientific Advisory Group (SAG) For Radiation Physics Chair: M. Schwarz (IT)

Members: M. Alber (DE), M. Aznar (DK), C. Clark (UK), A. Dekker (NL), C. Fiorino (IT), D. Georg (AT), E. Gershkevitsh (EE), N. Jornet (ES), R. Mackay (UK), G. Meijer (NL), L. Muren (DK), T. Nyholm (SE), J-J. Sonke (NL), J. Stroom (PT), K. Tanderup (DK), D. Thorwarth (DE)

Programme and Exhibition Guide | GENERAL INFORMATION

11

Scientific Advisory Group (SAG) For Brachytherapy Chair: C. Kirisits (AT)

Members: J-P. Calatayud (ES), C. Haie-Meder (FR), G. Kovács (DE), J. Lindegaard (DK), P. Papagiannis (GR), P. Petric (QA), B. Pieters (NL), C. Polgar (HU), B. Segedin (SI), F-A. Siebert (DE), A. Stewart (UK)

Scientific Advisory Group (SAG) For Clinical Radiotherapy Chair: K. Haustermans (BE)

Members: A. Bossi (FR), C. Faivre-Finn (UK), M. A. Gambacorta (IT), C. Grau (DK), M. Hoyer (DK), J. Jaal (EE), B. Jereczek-Fossa (IT), J. Kazmierska (PL), A. Kiltie (UK), V. Kouloulias (GR), H. Langendijk (NL), P. Lara (ES), P. Poortmans (FR), C. Rödel (DE), D. Zips (DE)

Scientific Advisory Group (SAG) For Radiation Therapy Chair: F. Moura (PT)

Members: B. Bak (PL), E. Bloemen (NL), A. Boejen (DK), M. Coffey (IE), I. Curic (SB), A. Duffton (UK), M. Kamphuis (NL), M. Leech (IE), I. Lobato (PT), Y. Man Tsang (IE), L. Mullaney (IE), P. Scherer (AT)

Scientific Advisory Group (SAG) For Radiobiology Chair : A. Chalmers (UK) Members: J. Alsner (DK), R. Coppes (NL), P. Hamerlik (DK), H. Lyng (NO), L. Marignol (IE), R. Syljuasen (NO), C. Vens (NL), M. Vooijs (NL), M-C. Vozenin (CH)

Young ESTRO Chairs: L. Dubois (NL), P. Franco (IT)

Members: J-E. Bibault (FR), G. Borst (NL), L. Mullaney (IE), K. Røe Redalen (NO), K. Rouschop (NL), M. Schmid (AT), M. Spałek (PL), D. Thorwarth (DE), W. van Elmpt (NL)

Abstracts Reviewers Abacioglu, M.U. (TR); Ahnesjö, A. (SE); Alber, M. (DE); Alderliesten, T. (NL); Aleman, B. (NL); Alonzi, R. (GB); Alsner, J. (DK); Anacak, Y. (TR); Andersen, C.E. (DK); Arcangeli, S. (PT); Arenas Prat, M. (ES); Aristei, C. (IT); Aznar, M. (GB); Bak, B. (PL); Baker, C. (GB); Bangert, M. (DE); Barazzuol, L. (NL); Barillot, I. (FR); Barton, M. (AU); Bastholt, L. (DK); Bedford, J. (GB); Bel, A. (NL); Belderbos, J. (NL); Belka, C. (DE); Belkacemi, Y. (FR); Belli, M.L. (IT); Bibault, J. (FR); Biete, A. (ES); Blanchard, P. (FR); Bloemen- van Gurp, E. (NL); Boejen, A. (DK); Boerma, M. (US); Boersma, L. (NL); Bol, G. (NL); Bonomo, P. (IT);

GENERAL INFORMATION | Programme and Exhibition Guide

12

Borgmann, K. (DE); Borras, J. (ES); Borst, G. (NL); Bossi, A. (FR); Boterberg, T. (BE); Bourgier, C. (FR); Bourhis, J. (CH); Bownes, P. (GB); Brada, M. (GB); Breedveld, S. (NL); Brink, C. (DK); Broggi, S. (IT); Brunner, T. (DE); Budach, W. (DE); Budgell, G. (GB); Buglione, M. (IT); Bujko, K. (PL); Burnet, N. (GB); Bussink, J. (NL); Buus, S. (DK); Cacicedo, J. (ES); Caetano Amador, Marco (PT); Cagni, E. (IT); Calandrino, R. (IT); Capone, L. (IT); Carlsson Tedgren, A. (SE); Carrie, C. (FR); Casar, B. (SI); Cavedon, C. (IT); Ceberg, C. (SE); Cella, L. (IT); Cellini, F. (IT); Chalmers, A. (GB); Chargari, C. (FR); Chiesa, S. (IT); Clark, Catharine (GB); Coffey, M. (IE); Coles, C. (GB); Coppes, R.P. (NL); Cordes, N. (DE); Corvò, R. (IT); Cozzarini, C. (IT); Cozzi, L. (IT); Crehange, G. (FR); Creutzberg, C. (NL); Curic Ilija (RS); Dasu, A. (SE); de Jong, R. (NL); De Meerleer, G. (BE); de Pooter, Jacco (NL); De Ruysscher, D. (NL); Dearnaley, D.P. (GB); Depuydt, T. (BE); Dickie, C. (CA); Dieckmann, K. (AT); Dirkx, Maarten (NL); do Carmo Oliveira, M. (PT); Dodwell, D. (GB); Dörr, W. (AT); Dubois, L. (NL); Duffton, A. (GB); Dunscombe, Peter (CA); Elstrøm, U.V. (DK); Eriksen, J.G. (DK); Eudaldo, T. (ES); Evans, P. (GB); Faithfull, S. (GB); Faivre-Finn, C. (GB); Ferrand, R. (FR); Filippi, A.R. (IT); Fiorentino, A. (IT); Fiorino, C. (IT); Fog, L. (DK); Fogliata, A. (IT); Fokas, E. (DE); Fonteyne, V. (BE); Forde, E. (IE); Fourquet, A. (FR); Fracchiolla, Francesco (IT); Franco, P. (IT); Frasca, S.C. (IT); Freeman, C.R. (CA); Gabrys, D. (PL); Gagliardi, G. (SE); Gambacorta, M.A. (IT); Garcia, R. (FR); Garibaldi, C. (IT); Georg, D. (AT); Gérard, J. (FR); Gershkevitsh, E. (EE); Giralt, J. (ES); Glynne-Jones, R. (GB); Gomà, C. (BE); Grantzau, T. (DK); Grau, C. (DK); Grégoire, V. (BE); Guckenberger, M. (CH); Guedea Edo, F. (ES); Guinot, J. (ES); Gutiérrez Miguélez, C. (ES); Haas, R. (NL); Haie-Meder, C. (FR); Hall, J. (FR); Hamerlik, P. (DK); Hannoun-Levi, J.M. (FR); Hansen, V.N. (GB); Hardcastle, N. (AU); Haustermans, K. (BE); Heemsbergen, W. (NL); Heijmen, B. (NL); Hellebust, T.P. (NO); Hennequin, C. (FR); Hernandez, V. (ES); Higgins, G. (GB); Hill, M. (GB); Hoffmann, A. (DE); Hoogeman, M. (NL); Hoskin, P. (GB); Hounsell, A.R. (GB); Hoyer, M. (DK); Hu, W. (CN); Hurkmans, C. (NL); Intven, M. (NL); Iori, M. (IT); Jaal, J. (EE); Jereczek-Fossa, B.A. (IT); Jiazhou, W. (CN); Johansen, J. (DK); Jornet, N. (ES); Jürgenliemk-Schulz, I. (NL); Kaidar-Person, O. (IL); Kamphuis, M. (NL); Karaiskos, P. (GR); Kazmierska, J. (PL); Kepka Lucyna (PL); Khoo, V. (GB); Kiltie, A.E. (GB); Kim, H.J. (KR); Kirisits, C. (AT); Kirkby, K. (GB); Kirkove, C. (BE); Kirova, Y. (FR); Knöös, T. (SE); Knopf, A. (NL); Korreman, S. (DK); Kostovski, A. (BA); Kouloulias, V. (GR); Kovács, G. (DE); Kraan, B. (NL); Krause, M. (DE); Kry, S. (US); Kuess, P. (AT); Kukolowicz, P. (PL); Lacornerie, T. (FR); Lagendijk, J. (NL); Lagerwaard, F. (NL); Lambrecht, M. (BE); Langendijk, H. (NL); Lara Jimenez, P.C. (ES); Lartigau, E. (FR); Lassen, P. (DK); Le Pechoux, C. (FR); Lechner, W. (AT); Leech, M. (IE); Lehmann, J. (AU); Leong, A. (NZ); Lievens, Y. (BE); Lindegaard, J.C. (DK); Livi, L. (IT); Lobato, I. (PT); Lomax, T. (CH); Lopez Torrecilla, J. (ES); Lorentini, S. (IT); Lyng, H. (NO); Mackay, R.I. (GB); Maduro, J.H. (NL); Maingon, P. (FR); Maldonado, J. (ES); Malicki, J. (PL); Malinen, E. (NO); Marchesi, V. (FR); Marignol, L. (IE); Marijnen, C. (NL); Marrazzo, L. (IT); Marta, G. (BR); Marzi, S. (IT); Mast, M. (NL); Mayles, P. (GB); Mc Andrew, N. (GB); Mc Garry, C. (GB); McClean, B. (IE); McGarry, M. (IE); McNair, H. (GB); Meattini, I. (IT); Meijer, G. (NL); Menten, J. (BE); Mijnheer, B. (NL); Mikhaeel, G. (GB); Minniti, G. (IT); Mirimanoff, R.O. (CH); Moeckli, R. (CH);

Programme and Exhibition Guide | GENERAL INFORMATION

13

Monshouwer, R. (NL); Montero Luis, A. (ES); Monti, A.F. (IT); Moura, F. (PT); Mullaney, L. (IE); Munck af Rosenschöld, P. (SE); Munoz Montplet, C. (ES); Muren, L.P. (DK); Murrer, L. (NL); Nailon, W. (GB); Nestle, U. (DE); Nieder, C. (NO); Nijkamp, J. (NL); Nisbet, A. (GB); Niyazi, M. (DE); Nordsmark, M. (DK); Nout, R. (NL); Nuver, T. (NL); Nuyts, S. (BE); Nyholm, T. (SE); Nyström, H. (SE); O'Donovan, A. (IE); Offersen, B. (DK); Ojala, J. (FI); Osztavics, A. (AT); Overgaard, J. (DK); Ozsahin, E.M. (CH); Ozyigit, G. (TR); Pallotta, S. (IT); Palmans, H. (AT); Palorini, F. (IT); Panettieri, V. (AU); Pantelis, E. (GR); Papagiannis, P. (GR); Paris, F. (FR); Peitzsch, C. (DE); Perez-Calatayud, J. (ES); Perrier, L. (FR); Peters, F. (NL); Petit, S. (NL); Petric, P. (QA); Pettingell, J. (GB); Philippens, M. (NL); Pieters, B. (NL); Platoni, P. (GR); Polgár, C. (HU); Polo Rubio, J.A. (AT); Poole, C. (IE); Poortmans, P. (FR); Popovitzer, A. (IL); Pötter, R. (AT); Price, G. (GB); Pruschy, M. (CH); Raaymakers, B. (NL); Rades, D. (DE); Ramella, S. (IT); Rancati, T. (IT); Rasch, C. (NL); Ree, A.H. (NO); Reynaert, N. (BE); Riboldi, M. (IT); Ricardi, U. (IT); Richter, C. (DE); Rieken, S. (DE); Riesterer, O. (CH); Rijnders, A. (BE); Rivera, S. (FR); Rödel, C. (DE); Rodemann, H.P. (DE); Røe Redalen, K. (NO); Romero, R. (ES); Rossi, L. (NL); Russell, N. (NL); Salembier, C. (BE); Sanchez-Doblado, Francisco (ES); Sarrut, D. (FR); Scalliet, P. (BE); Schettino, G. (GB); Schmid, M. (AT); Schwarz, M. (IT); Scoccianti, S. (IT); Sedlmayer, F. (AT); Sen, M. (GB); Senan, S. (NL); Seppenwoolde, Y. (AT); Sharif, A. (GB); Shields, L. (IE); Siebert, F. (DE); Skladowski, K. (PL); Slosarek, K. (PL); Slotman, B. (NL); Smeenk, R.J. (NL); Sonke, J. (NL); Spalek, M. (PL); Specht, Lena (DK); Stans, R. (BE); Stasi, M. (IT); Sterpin, E. (BE); Stevanovic, J. (RS); Stewart, A. (GB); Stieler, F. (DE); Stock, M. (AT); Stokkevåg, C. (NO); Strnad, V. (DE); Stroom, J. (PT); Sun Myint, A. (GB); Sundaresan, P. (AU); Syljuasen, R. (NO); Tan, L. (GB); Thörnqvist, S. (NO); Thorwarth, D. (DE); Timmermann, B. (DE); Tomé, W. (US); Torresin, A. (IT); Troost, E. (DE); Tsang, Y.M. (GB); Tsoutsou, P. (CH); Turtle, L. (GB); Vaandering, A. (BE); Valentini, V. (IT); van Asselen, B. (NL); Van de Kamer, J. (NL); Van den Heuvel, Frank (GB); van der Heide, U. (NL); van der Horst, A. (NL); van der Linden, Y. (NL); Van Der Schaaf, A. (NL); van Elmpt, W. (NL); Van Limbergen, E. (BE); Van Loon, J. (NL); van Luijk, P. (NL); van Rossum, P. (NL); van Vulpen, M. (NL); Vanderstraeten, B. (BE); Vasquez Osorio, E.M. (GB); Vens, C. (NL); Verellen, D. (BE); Verheij, M. (NL); Vestergaard, A. (DK); Vogelius, I.R. (DK); Vordermark, D. (DE); Vozenin, M. (CH); Widesott, L. (IT); Wiegel, T. (DE); Witte, M. (NL); Wittkämper, F. (NL); Woodings, S. (NL); Yahalom, J. (US); Zapatero Laborda, A. (ES); Zilli, T. (CH); Zips, D. (DE); Zubizarreta, E.H. (AT)

GENERAL INFORMATION | Programme and Exhibition Guide

14

About ESTRO

ESTRO Vision 2020 Every cancer patient in Europe will have access to state of the art radiation therapy, as part of a multidisciplinary approach where treatment is individualised for the specific patient’s cancer, taking account of the patient’s personal circumstances. ESTROMission Founded in 1980, ESTRO is a non-profit scientific organisation whose role is to foster, in all its aspects, radiation oncology, clinical oncology and related subjects, including physics as applied to radiotherapy, radiation technology and radiobiology. To fulfill its purpose, ESTRO promotes education, science, research and advocate for access to radiotherapy through its teaching courses, workshops, meetings, publications and public affairs activities. ESTRO School The ESTRO School has become an internationally recognised provider of high quality education in radiotherapy and oncology and has developed a wide array of educational activities: • Live teaching courses covering basic and continuing medical educational needs of all professionals working in the field of (radiation) oncology • Pre-meeting teaching courses, workshops, teaching lectures and tumour boards during congresses • Live and online workshops courses with FALCON (Fellowship in Anatomic deLineation and CONtouring), the online delineation programme • Hands-on experience through mobility grants programme. The ESTRO School promotes multidisciplinary education in oncology, basic science, physics and technology, imaging, and interdisciplinary oncology, with the objective of standardising knowledge and clinical practice, whilst recognising the diversity of radiation oncology practice in different parts of the world. In 2018, the ESTRO School is organising 36 live courses (29 in Europe and seven outside Europe) and two undergraduate courses. More information on the 2018 course programme on www.estro.org

Programme and Exhibition Guide | GENERAL INFORMATION

15

ESTRO Conferences ESTRO next annual conference: ESTRO 38 26-30 April 2019 | Milan, Italy

ESTRO 38 will focus on the latest data in clinical oncology, radiation physics, radiation technology and patient’s care, brachytherapy and radiobiology, all contributing to the ultimate goal: a better patients’ outcome in cancer treatment.

ESTROMembership The ESTRO memberships gathers 7,300 professionals of radiation oncology and its related fields, providing them with the resources and tools they need to successfully support their career development. ESTRO members can benefit from a host of advantages such as: • Online subscription to Radiotherapy & Oncology , the Society’s journal • Reduced fees for attending ESTRO conferences, teaching courses and online workshops A wide range of oncology professions are represented within the ESTRO community: radiation oncologists, clinical oncologists, medical physicists, radiobiologists, radiation therapists (RTTs), dosimetrists, radiotherapy nurses, medical oncologists, surgeons, industry representatives, organ specialists, other medical and non-medical professions, coming from more than 100 countries spread all over the world. 2018 membership is available on the ESTRO website and at the ESTRO booth during ESTRO 37, booth #100, in the exhibition hall. More information on www.estro.org • Online access to scientific material through the e-library (DOVE) • Eligibility for grants, awards, faculties and governance positions. Radiotherapy & Oncology, the Green Journal, is the flagship publication in ESTRO’s family of journals. The Journal publishes original research articles and review articles on all aspects of radiation oncology and has a current impact factor of 4,328. www.thegreenjournal.com Open access journals ESTRO and Elsevier have launched more recently three new open access journals in order to provide specialised venues for the publication of ESTRO members’ work: • Clinical and Translational Radiation Oncology – ctRO, www.ctro.science • Physics and Imaging for Radiation Oncology – phiRO, www.phiro.science • Technical Innovations and Patient Support in Radiation Oncology – tipsRO, www.tipsro.science ESTRO Publications Radiotherapy & Oncology

GENERAL INFORMATION | Programme and Exhibition Guide

16

Programme and Exhibition Guide | GENERAL INFORMATION

17

CME accrediation

ESTRO 37, Barcelona, Spain, 20/04/2018-24/04/2018 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 22 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit- participation-international-activities. Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

GENERAL INFORMATION | Programme and Exhibition Guide

18

General information

Venue CCIB Rambla Prim 1-17 08019 Barcelona Spain

Opening hours • Wednesday 16:00 – 18:00 (group registration only / badges pick-up for corporate members starting at 14:00) • Thursday 16:00 – 18:00 • Friday 07:30 – 19:00

• Saturday 07:00 – 18:00 • Sunday 07:00 – 18:00 • Monday 07:00 – 18:00 • Tuesday 07:00 – 13:00

Accommodation Kuoni Congress is the appointed official housing agent for ESTRO 37 and will operate an accommodation desk in the registration area on: • Thursday 16:00 – 18:00 • Friday 09:00 – 19:00

• Saturday 09:00 – 18:00 • Sunday 09:00 – 18:00 • Monday 09:00 – 18:00 • Tuesday 09:00 – 12:00

Assemblies • The GEC-ESTRO Assembly will be held on Saturday 21 April from 13:30 – 14:30 | Room 120/121 • The Physics Assembly will be held on Monday 23 April from 13:30 – 14:30 | Room 120/121 • All ESTRO members are invited to attend the General Assembly on Monday 23 April 18:40 | Room 111 • Radiobiology Committee Meet and Greet Sunday 22 April from 12:00 to 13:00 | Room 127 • RTT Committee Meet and Greet Monday 23 April from 12:00 to 13:00 | Room 122

Programme and Exhibition Guide | GENERAL INFORMATION

19

Badges Upon registration participants will receive a personal name badge and are kindly requested to wear this badge when attending scientific sessions and/or social events.

Certificates Certificates of attendance will be issued as of Monday 23 April through the designated stations in the registration area. Certificates of attendance can also be downloaded online until three months after the event. Communities Pavilion The Communities Pavilion will gather institutes, national societies, international radiation oncology societies, patients’ associations and other oncology associations in the exhibition area that will welcome attendees on dedicated booths in order to exchange information about science, projects and collaborations as well as job opportunities and mutual interests. Entrance to Communities Pavilion is free to all the ESTRO 37 participants and is open from 20-23 April since starts with the networking evening during the exhibition opening times. Posters Electronic poster stations will allow you to view the virtual displays at your leisure and to correspond with presenters or forward a presentation to a colleague or home office. A limited number of posters will also be displayed in the poster area during the whole congress. Exhibition An exhibition featuring equipment and pharmaceutical companies as well as medical publishers will be held in the Exhibition area. The exhibition will be open on Friday 20 April with the networking evening until Monday 23 April. Information for abstract authors ESTRO 37 abstracts were selected for the following types of presentations: • Oral communication Abstract is presented in one of the proffered papers sessions. • Poster viewing Posters selected for the poster viewing sessions will be highlighted in the conference Opening hours: between 09:30-17:00 each day. Entrance is free for all registered participants.

GENERAL INFORMATION | Programme and Exhibition Guide

20

final programme and will be displayed in a central section of the poster area. Posters on a similar topic will be grouped together. The presenting authors of the selected posters in the group will visit all the posters within each group, along with the audience. At each poster, the presenting author will present his/her poster in five minutes, followed by three minutes for discussion, which will be led by two chairpersons for the group. • Poster Authors are required to display a poster on the designated poster panel. Posters are grouped by topic. - poster mounting time: posters can be mounted as of 16:00 on Thursday 19 April 2018 or anytime after that - poster removal time: posters should be removed by Tuesday 24 April 2018 before 13:00. Any posters remaining after that time will be discarded. Authors are requested to be present next to their poster during the poster reception which will be held on Saturday 21 April 2018 as of 18:40. It will also be indicated in the official schedule that posters can be viewed during lunch time on Sunday 22 April and Monday 23 April 2018. • E-poster Authors upload an electronic poster in the ESTRO system. E-posters will be available for viewing in special stations available at the conference venue, anytime during the conference. There is no designated time slot for viewing. Participants will be able to view all electronic posters as frequently, and as often as they wish. • In the electronic abstract book : - Oral Communication abstracts are designated with OC + number - Poster Viewing abstracts are designated with PV + number - Posters are designated with PO + number - Electronic Posters are designated with EP + number. Insurance The organiser does not accept liability for individual medical, travel or personal insurance. Participants are strongly advised to take out their own personal insurance policies. In case an unforeseen event would force ESTRO to cancel the meeting, the Society will reimburse the participants the registration fee minus 15% for handling charges. ESTRO will not be responsible for the refund of travel and accommodation costs. Luncheons and refreshments The registration fee for the conference includes coffee breaks to all participants and exhibitors wearing their conference badges. Lunch will be available for purchase in the exhibition area and is not included in the registration.

Programme and Exhibition Guide | GENERAL INFORMATION

21

Meeting points Special designated meeting points for each ESTRO discipline are located near the poster area.

Opening ceremony and networking evening All participants and company delegates are invited to the official opening ceremony which will be held in the main auditorium on Friday 20 April 2018 at 18:30. The opening ceremony will be followed by the networking evening which will take place in the exhibition area. Programme • 18:30-18:45 > Welcome note by Y. Lievens • 18:45-19:15 > Keynote lecture: Health Systems, Innovation and Value Based Healthcare Rifat Atun (USA)

Satellite symposia Commercial satellite symposia will be held after the pre-meeting courses and during lunch breaks. See “Satellite Symposium" section of this book on page 407 for more information.

Smoking There will be a strict non-smoking policy within all areas of the conference facilities.

Social Activities • Friday 20 April 2018

All registered participants and all company delegates are invited to the networking evening which will take place in the exhibition area as of 19:20 on Friday 20 April. • Saturday 21 April 2018 All participants and company delegates are invited to the poster awards ceremony, which will be held in the poster area on Saturday 21 April at 18:40. • Sunday 22 April 2018 The 4 th Super Run will take place at Parc del Camp de la Bota in front of ESTRO 37 main entrance at 19:00. The five km run is organised for the benefit of the ESTRO Cancer Foundation. With more than 500 runners, including patients who are demonstrating that being physically active during treatment is possible, the Super Run is the opportunity to meet altogether in a relaxed atmosphere and share the same effort in the fight against cancer.

GENERAL INFORMATION | Programme and Exhibition Guide

22

More details on: https://www.estro.org/congresses-meetings/articles/estro-cancer- foundation-e37 • Monday 23 April 2018 All participants are welcome to the after dinner, which will take place in an exclusive venue in Barcelona. Additional tickets for this event are available for purchase Speaker preview The speaker preview room is located in the main congress area. Speakers are requested to bring their PowerPoint presentations to the speaker preview room at least three hours prior to the start of the session or the day before if the session is planned in the early morning.

Opening hours • Thursday 16:00 – 18:00 • Friday 07:00 – 18:00 • Saturday 07:00 – 18:00 • Sunday 07:00 – 18:00 • Monday 07:00 – 18:00 • Tuesday 07:00 – 13:00

Wifi Free wireless internet will be available in all meeting rooms.

Programme and Exhibition Guide | GENERAL INFORMATION

23

Acknowledgements

ESTRO would like to extend a special thank you for the Chair of ESTRO 37, Yolande Lievens and the Chairs of the Advisory Groups, Umberto Ricardi, Christian Kirisits, Karin Haustermans, Marco Schwarz, Filipe Moura, Anthony Chalmers, Ludwig Dubois, Pierfrancesco Franco for having accepted the responsibility to develop the scientific programme. Special thanks to all the members of the scientific advisory groups, local organizing committee and abstract reviewers for their valuable contribution to the conference.

ESTRO welcomes as special guests:

ASTRO – American Society for Radiotherapy and Oncology EFOMP – European Federation of Organisations for Medical Physics EORTC- European Organization for Research and Treatment Cancer ESGO – European Society of Gynaecological Oncology ESR – European Society for Radiology PROS – Paediatric Radiation Oncology Society

GENERAL INFORMATION | Programme and Exhibition Guide

24

ESTRO 37 APP

Download the ESTRO 37 app – your indispensable guide to the congress

SESSIONS You can check out the sessions you wish to attend, view their summary and add them to your personal agenda. SPEAKERS You can view biographies, select congress speakers, send them messages and add them to your own personal agenda. EVALUATION You can vote and evaluate speakers and sessions. MY EVENT This is your personal agenda, displaying your selected sessions, speakers, exhibitors and much more. EXHIBITION Thanks to the interactive floor plan, you can easily access the information on the booths and exhibitors you wish to visit and save them to your personal agenda. NETWORKING Interact with other attendees at the event via the messaging service. You can send messages privately and arrange meetings that will be scheduled in your personal agenda. SOCIAL MEDIA Stay up-to-date with the latest congress news by using Twitter (#ESTRO37), LinkedIn and Facebook.

that also allows you to vote and evaluate sessions and speakers.

DOWNLOADTHEAPP FROMWWW.ESTRO.ORG

ABSTRACT BOOK The abstract book will be directly downloadable from the app.

NOTES

NOTES | Programme and Exhibition Guide

26

NOTES

ESTRO AWARDS

Awards overview

28

Awardees’ biographies

30

Programme and Exhibition Guide | NOTES

27

Awards overview

Lifetime Achievement Award Rob Glynne-Jones (UK)

Michael Joiner (USA) Richard Pötter (AT) David Thwaites (AU) Erik Van Limbergen (BE)

ESTRO Award Lectures • Emmanuel van der Schueren Award The ESTRO School - Radiation oncology education of the highest standard for all Christine Verfaillie (BE) Saturday 21 April | from 12:30 – 13:00 | Room Auditorium • Donal Hollywood Award Residual setup errors after IGRT are linked to overall survival in lung and oesophageal cancers Corinne Johnson (UK) Sunday 22 April | from 12:00 – 12:10 | Room Auditorium • Iridium Award The dose rate effect in brachytherapy Jean-Jacques Mazeron (FR) Sunday 22 April | from 17:45 – 18:15 | Room Auditorium

• Klaas Breur medal Award

Biological Precision in Radiotherapy Gillies McKenna (UK) Monday 23 April | from 12:30 – 13:00 | Room Auditorium

• Jens Overgaard Legacy Award This is not a Target Volume… Vincent Grégoire (BE) Monday 23 April | from 17:40 – 18.00 | Room Auditorium

ESTRO AWARDS | Programme and Exhibition Guide

28

Honorary Members Lectures • Imaging in Oncology - let’s shape the future together Regina Beets-Tan (NL) Saturday 21 April | from 17:45 – 18:00 | Room Auditorium • Sustaining Radiotherapy Services and Development in Low Middle-Income Countries Soehartati Gondhowiardjo (ID) Saturday 21 April | from 18:00 – 18:15 | Room Auditorium • Radiotherapy of Hodgkin Lymphoma: Revolutionary Roots, Challenging Present, Bright Horizons Joachim Yahalom (USA) Saturday 21 April | from 18:15 – 18:30 | Room Auditorium ESTRO sponsors three poster awards for a clinician, a physicist and a radiation therapist (RTT). Awards winners will be announced and prizes handed out at the poster awards ceremony. Saturday 21 April 2018 | as of 18:40 | Poster area • ctRO, phiRO, tipsRO Young Investigator Awards Sponsored by Elsevier Awards winners will be announced and prizes handed out at the poster reception. Saturday 21 April 2018 | as of 18:40 | Poster area ESTRO Academic Award • Jack Fowler University of Wisconsin Award First clinical demonstration of online real-time liver tumor motion monitoring on a standard linac Jenny Bertholet (DK) Monday 23 April | from 18:00 – 18:10 | Room Auditorium Poster Awards • ESTRO Poster Awards

Programme and Exhibition Guide | ESTRO AWARDS

29

Awardees’ biographies

LIFETIME ACHIEVEMENT AWARD

Rob Glynne-Jones Mount Vernon Centre for Cancer Treatment, Northwood, UK

Dr Robert Glynne-Jones is the Macmillan Lead Clinician in Gastrointestinal and Colorectal Cancer at Mount Vernon Centre for Cancer Treatment and Chief Medical Advisor to the national charity ‘Bowel Cancer UK’. He gained a BA in Classics (Literae Humaniores) as his first degree at Oxford (1968-1972) and did his medical training at Guy’s Hospital qualifying in 1978. Dr Robert Glynne-Jones is a member of the European Society for Therapeutic Radiology and Oncology (ESTRO), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO) – all of which he has served with a long-term teaching role. He is a member of the EORTC GI Group, the UK NCRI colorectal group, and until recently chaired the NCRI Anal Cancer Studies Group. Dr Robert Glynne-Jones has been a member of National Institute for Clinical excellence (NICE) committees responsible for producing ‘Guidance for Colorectal Cancer’ and ‘Quality Standards for Colorectal Cancer’, and recently a NICE committee which recommended universal testing for Lynch syndrome (2017). He has been lead for developing ESMO Guidelines in Anal Cancer (2014) and rectal cancer (2017). With a lifelong interest in communications skills, for many years he has been part of a national initiative in training clinicians and promoting patient choice – currently contributing to a new ESTRO communication skills course. His research interests lie in rectal and anal cancer with more than 180 peer reviewed publications. His main objectives have been to ensure a ‘common language’ and clarity in the use of imaging, staging and the use of early/surrogate endpoints.

Rob Glynne-Jones

ESTRO AWARDS | Programme and Exhibition Guide

30

LIFETIME ACHIEVEMENT AWARD

Michael Joiner Wayne state University Detroit, Michigan, USA

Michael Joiner MA, PhD, MRCR (Hon), is Head of Radiobiology at the Karmanos Cancer Institute and the Graduate Officer of the Division of Radiation Oncology, Department of Oncology at Wayne State University, Detroit, Michigan, where he teaches. He is also an internationally recognized radiobiologist and researcher who has spent more than 40 years investigating how clinical radiotherapy can be made more effective using both manipulations of the radiation delivery schedule and also by the addition of chemical or physical modifiers of effect. Dr Joiner is an expert particularly in quantifying radiation effects, the medical physics of radiation delivery and application of high-LET radiotherapy. He discovered low-dose hyper-radiosensitivity, a major factor determining the extent of DNA repair following radiotherapy exposure. Before joining Wayne State University in 2001, Joiner spent 22 years at the Gray Laboratory in the UK, where he headed Experimental Oncology. Prior to this, he received his Masters degree from Cambridge University and his PhD in 1980 from the Royal Marsden Hospital in London. In 1999 he was made an honorary member of the Royal College of Radiologists for his services to them in teaching and examination. Dr Joiner has been a proud member of ESTRO for over 30 years and has been teaching and directing, the international ESTRO basic clinical radiobiology course. He has published more than 160 NCBI-cited peer-reviewed articles and he is the lead editor of the textbook, “Basic Clinical Radiobiology”. Dr Joiner truly nurtures a passion for teaching: next September, he will be teaching for ESTRO for the 40 th time.

Michael Joiner

Programme and Exhibition Guide | ESTRO AWARDS

31

LIFETIME ACHIEVEMENT AWARD

Richard Pötter Department of Radiation Oncology, Medical University of Vienna Vienna, Austria

Dr Richard Pötter is radiation oncologist and was also trained as diagnostic radiologist. After graduating in 1975 in medicine from the University of Münster, Germany, he first focused on surgery and internal medicine. He obtained his academic degree in radiation oncology on “Imaging in Radiotherapy” developing “MRI simulation” in 1989. Richard Pötter was full Professor and Chairman of the Department of Radiation Oncology at the Medical University of Vienna and the Vienna General Hospital from 1993 to 2016. With his team, in particular with Dr Karin Dieckmann and Dr Dietmar Georg, he promoted numerous developments in different areas of radiation oncology, with his main interest in image guided radiotherapy, brachytherapy and particle therapy (MedAustron, ENLIGHT, ULICE). He implemented MRI for radiotherapy in Vienna in 1998. Dr Pötter coordinated GEC-ESTRO from 1999 to 2003 and was the clinical editor for “Radiotherapy and Onocology” from 2006 until 2014. MRI guided gynecologic brachytherapy has finally become his major area of R&D: new MRI based technology (intracavitary/interstitial) and the adaptive target concept (CTVHR) together with Dr Erik van Limbergen, Dr Christine Haie-Meder and Dr Christian Kirisits (GEC ESTRO Recom. 2005/2006). He created the Gyn GEC ESTRO network, nowadays coordinated through Dr Kari Tanderup. Together with these partners and Dr Jacob Lindegaard, he initiated the EMBRACE study and research group in 2008. He also coordinated the “ICRU GEC ESTRO Report 89” on Cervix Cancer Brachytherapy from 1998 until 2016. Dr Pötter has been an ESTRO member since 1985 and has been involved in education and training at the ESTRO School: in radiation oncology, in general brachytherapy (1993-2008), in gynecologic brachytherapy (since 2004, since 2017 in India); GEC ESTRO Handbook of Brachytherapy (2002; since 2014 2 nd edition); international fellows; regular hands-on gynecologic workshops in Vienna and Asia. He was chair of the ESTRO School from 2006 until 2016 together with Ms Christine Verfaillie and a large team of experts with the aim of strengthening the ESTRO School and the education reach, especially in Asia.

Richard Pötter

ESTRO AWARDS | Programme and Exhibition Guide

32

LIFETIME ACHIEVEMENT AWARD

David Thwaites Institute of Medical Physics, School of Physics, University of Sydney (and The Sydney West Cancer Network, Westmead Hospital) Sydney, Australia; and Division of Biomedical Imaging (Medical Physics), University of Leeds and Leeds Teaching Hospitals, Leeds UK

David Thwaites completed his PhD (1978) and follow-on post-doc on radiation interactions in organic materials at Dundee University, Scotland, including work in the USA (Fermilab) and Denmark (Aarhus University and Niels Bohr Institute). He then held progressively senior clinical/academic medical physics posts in the Edinburgh Cancer Centre/Edinburgh University until 2004/5 when he moved to Leeds. Here, he became Professor of Oncology Physics, led the Radiotherapy Physics service into a large new cancer centre, established a radiotherapy research facility, and headed the Medical Physics and Engineering department. In 2011 he became Professor and Director of the Institute of Medical Physics at Sydney University, with a Health Ministry advisory role and honorary clinical posts in W/SW Sydney hospitals. His scientific interests range from fundamental physics to translational research (including in radiation dosimetry/modelling, radiotherapy imaging and treatment methods/modalities, accuracy/quality/safety, and, recently, bioinformatics/machine-learning applications). He has approaching 250 papers, book chapters and books. He has contributed to a wide range of national and international (notably ESTRO, IAEA, IOMP) scientific, professional and educational initiatives in medical physics and radiation oncology. For ESTRO, this includes via Board membership (1998-2006), the Physics Committee (1990-, chair 2003-06), Education Committee, conference scientific committees, Physics Editorship of Radiotherapy and Oncology since 1992, and many project and guideline groups. He received honorary FRCR in 2008, the ESTRO Emmanuel van der Schueren Award in 2014 and an IOMP 50 th anniversary award in 2013 for international contributions. He and Catherine married in 1978 and he has greatly valued her unstinting support throughout his career.

David Thwaites

Programme and Exhibition Guide | ESTRO AWARDS

33

LIFETIME ACHIEVEMENT AWARD

Erik Van Limbergen University Hospital Gasthuisberg Leuven, Belgium

Erik Van Limbergen (1953), MD, PhD, is senior radiation oncologist at the University Hospital Gasthuisberg in Leuven, Belgium. He is married since 1979 and has three children. After obtaining a medical degree maxima cum laude at the Leuven University, he completed his training in Radiation Oncology at the University Hospitals in Leuven (1977- 1981), at the Institut Gustave Roussy in Villejuif, and at the Hôpital Henry Mondor, Créteil Paris, France (1981-1982). He obtained a certificate in Radiobiology at the Université Paris XIII Kremlin Bicêtre (1982). In 1993, he obtained a PhD degree with his thesis “Breast Conserving Treatment for Breast Cancer: a decision making model based on qualitative and quantitative clinical parameters” . Since 1983 he is staff member at the University Hospitals in Leuven working in the field of breast, gynaecological, skin cancers and soft tissue sarcomas. He is coordinator of the Leuven University Centre for Cancer Prevention (LUCK) and took actively part in the implementation of the Flemish breast screening programme (2001) and the development of guidelines on screening, diagnosis and treatment of breast cancer. He is the present chair (since 2012) of the CvKO (Centre for Early Detection of Cancer) that runs the screening programmes for breast, cervix and colon cancer in Flanders. Prof Van Limbergen is an active member of the European SocieTy for Radiotherapy & Oncology (ESTRO) and past chair of the GEC-ESTRO Brachytherapy Committee. He is been teaching at ESTRO since 1996 and was director of the GEC-ESTRO Teaching Course of Modern Brachytherapy Techniques from 2001 till 2016. He was co–editor of the GEC-ESTRO Handbook of Brachytherapy 1st and now 2 nd edition, and co-author of GEC-ESTRO recommendations on endovascular brachytherapy (2001), breast APBI selection criteria (2010), GEC ESTRO (2005-2006) and GEC-ESTRO–ICRU recommendations (2016) for cervix cancer brachytherapy. He is author / co-author of more than 325 articles, published abstracts, and book chapters. He became honorary member of the Austrian Society of Radiation Oncology in 2004 and of the Société Française de Radiothérapie Oncologie in 2008.

Erik Van Limbergen

ESTRO AWARDS | Programme and Exhibition Guide

34

ESTRO AWARD LECTURES - EMMANUEL VAN DER SCHUEREN AWARD

Christine Verfaillie ESTRO office Brussels, Belgium

Christine Verfaillie studied Modern History and Library & Information Science. She started working as Librarian at an educational college, moved on to work as Manager Central European projects at IBO, an international NGO for community building and joined ESTRO in 1995 as Congress Manager. From 1998 to 1999, she was Director of the events team at the Tourist Board of Ostend. She returned to ESTRO and contributed since 2000 to the further development and strengthening of ESTRO as a scientific society. She has been particularly committed to the ESTRO School and enjoyed supporting the expansion of the School’s activities, the innovation and improvement of the educational programs, the collaboration with the numerous teachers and tutors sharing their competencies voluntarily and is enthusiastic to carry the School forward on its international journey, for the benefit of cancer patients worldwide. Christine currently is Managing Director Education and Science at ESTRO.

Christine Verfaillie

Programme and Exhibition Guide | ESTRO AWARDS

35

DONAL HOLLYWOOD AWARD

Corinne Johnson Manchester Cancer Research Centre, The University of Manchester, The Christie NHS Foundation Trust Manchester, UK

Corinne graduated with a BSc (Hons) in Physics from the University of Edinburgh, Scotland, in 2012, and an MSc in Medical Physics from the University of Aberdeen, in 2013, before commencing clinical scientist training, specializing in radiotherapy, at Raigmore Hospital in Inverness. In January 2015, she joined the Radiotherapy Related Research group at the Manchester Cancer Research Centre to undertake her doctoral studies as part of the theragnostics project. The theragnostics team applies machine learning and data mining techniques to routine clinical data with the aim of predicting clinical outcomes for radiotherapy treatment individualization. Corinne’s PhD project primarily focuses on lung cancer, with her initial work addressing the problems in combining patient cohorts with differently defined target volumes. Her principal research interest is in how patient changes that occur throughout the course of radiotherapy might affect or predict the success and toxicity of a treatment. Her recent work has demonstrated a link between residual set-up errors in image guided radiotherapy and overall survival in non-small cell lung cancer patients and suggests cardiac dose could be a factor. Following the completion of her PhD, Corinne intends to pursue a joint clinical and research career in radiotherapy physics.

Corinne Johnson

ESTRO AWARDS | Programme and Exhibition Guide

36

IRIDIUMAWARD

Jean-Jacques Mazeron Sorbonne University – Hospital Pitié-Salpêtrière Paris, France

Jean-Jacques Mazeron, MD, PhD, is professor of radiation oncology at the Sorbonne University, Paris, and radiation oncologist at the Pitié-Salpêtrière Hospital. He chaired the medical division of the Orsay Protontherapy Centre from 1999 to 2004 as well as the department of radiation oncology at the Hospital Pitié-Salpêtrière from 2004 to 2016. Dr Mazeron chaired SFRO (Société Française de Radiothérapie Oncologique) in 2008 and 2009 and is now the Administrative Director of SFRO. In 1997, he founded the journal of SFRO Cancer/Radiothérapie and is still its Editor-in-Chief. He chaired the GEC-ESTRO from 2003 to 2006. He participated in the ESTRO annual teaching course on brachytherapy from 1990 to 2005. He was one of the editors of the GEC-ESTRO handbook of brachytherapy, published in 2002, and has edited several textbooks of radiation therapy in France.

Jean-Jacques Mazeron

Programme and Exhibition Guide | ESTRO AWARDS

37

JENS OVERGAARD LEGACY AWARD

Vincent Grégoire Université Catholique de Louvain, St-Luc University Hospital Brussels, Belgium

Professor Vincent Grégoire graduated as a Medical Doctor (MD) in 1987 from the Université Catholique de Louvain in Belgium. He was board certified in Radiation Oncology in Belgium in 1994 and obtained his PhD in Radiation Biology in 1996 after a fellowship at the Netherlands Cancer Institute in Amsterdam (The Netherlands) and at MD Anderson Cancer Center in Houston (USA). Professor Grégoire is currently Director of the Center for Molecular Imaging, Oncology and Radiotherapy, Full Professor in Radiation Oncology, and Head of Clinic in the Department of Radiation Oncology. He coordinates the Head and Neck Oncology program where the publications of the consensus guidelines for selection and delineation of target volumes brought him worldwide recognition. Vincent Grégoire is director or co-director of 15 PhD theses and is author or co-author of 258 peer-reviewed publications and 16 book chapters. He has delivered more than 850 abstract presentations, lectures or teaching seminars worldwide. He has been the President of ESTRO from 2007 to 2009. He is currently vice-President of the board of EORTC, past-Chairman of the Radiation Oncology Group of the EORTC and Chairman of the Head & Neck group of the EORTC. He is a member of the ICRU main commission and of the board of Director of ICRU. In 2008, he was awarded Honorary Fellow of the British Royal College of Radiology, and in 2016 Honorary Fellow of the Irish College of Radiology. In 2014 he received the Breur Award from ESTRO and in 2015, he was awarded Honorary ESTRO Physicist.

Vincent Grégoire

ESTRO AWARDS | Programme and Exhibition Guide

38

KLAAS BREUR MEDAL AWARD

Gillies McKenna CRUK/MRC Oxford Institute for Radiation Oncology Oxford, UK

Professor Gillies McKenna graduated 1972 from the University of Edinburgh; he then studied for an M.D. and Ph.D. in Cell Biology from Albert Einstein College of Medicine in New York. After postgraduate training at Johns Hopkins Hospital and the US National Cancer Institute, Professor McKenna joined the University of Pennsylvania School of Medicine in Philadelphia in 1987, where he became the Henry K. Pancoast Professor and Chairman of Radiation Oncology. His major interest is the study of the molecular mechanisms underlying the resistance of some cancers to treatment with radiation or with chemotherapy. He is interested in developing strategies to render some of the most resistant tumours more sensitive to treatment and is working to bring some of his research discoveries into clinical trial. Professor McKenna has received several awards and honours including a Scholar’s Award from the Radiological Society of North America, a Career Development Award from the American Cancer Society, the Weiss medal from the Association for Radiation Research, the Röntgen Medal from the Deutches Röntgen Museum, Germany and most recently the Gold Medal from the Royal College of Radiologists. Professor McKenna moved to Oxford in 2005 and is the Director of the CRUK/MRC Oxford Institute for Radiation Oncology. He was Head of the Department of Oncology from 2010 to April 2017. He works closely and serves on scientific boards with external funding bodies and partners. He is a Fellow of the Royal College of Radiologists, the Academy of Medical Sciences and of the Royal Society of Biology.

Gillies McKenna

Programme and Exhibition Guide | ESTRO AWARDS

39